Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

BACKGROUND: Disease-modifying drug use necessitates better Alzheimer disease (AD) detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk group; similarly, mild behavioral impairment (MBI) leverages behavioral change. Adding MBI to MCI improves dementia prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Zahinoor, Leon, Rebeca, Creese, Byron, Ballard, Clive, Robert, Philippe, Smith, Eric E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386685/
https://www.ncbi.nlm.nih.gov/pubmed/37516848
http://dx.doi.org/10.1186/s13024-023-00631-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386685/
https://www.ncbi.nlm.nih.gov/pubmed/37516848
http://dx.doi.org/10.1186/s13024-023-00631-6

Ejemplares similares